| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2265.1999.00867.X |
| P698 | PubMed publication ID | 10619976 |
| P2093 | author name string | Sugimoto T | |
| Chihara K | |||
| Nasu M | |||
| Sugishita T | |||
| Kanzawa M | |||
| Nakaoka D | |||
| P2860 | cites work | Effects of human growth hormone in men over 60 years old | Q28288413 |
| Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms | Q30449804 | ||
| A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers | Q34795311 | ||
| Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin | Q36422821 | ||
| Treatment of osteoporosis with calcitonin, with and without growth hormone | Q36493620 | ||
| Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement | Q36719559 | ||
| Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males | Q36760490 | ||
| Growth hormone and adult bone remodelling | Q36906806 | ||
| Impaired growth hormone secretion in the adult population: relation to age and adiposity | Q36998642 | ||
| Effects of Human Growth Hormone on Body Composition in Elderly Men | Q37026939 | ||
| Growth hormone, body composition, and aging | Q39832588 | ||
| Insulin-like growth factors and bone: the osteoporosis connection | Q40765294 | ||
| Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis | Q40810631 | ||
| Human growth hormone and human aging | Q40906146 | ||
| Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle | Q41349944 | ||
| Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro | Q41491080 | ||
| Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3 | Q42483106 | ||
| Growth hormone replacement in healthy older men improves body composition but not functional ability | Q43506669 | ||
| Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radio-immunoassay | Q43801474 | ||
| Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism | Q44052574 | ||
| Effect of growth hormone on vitamin D metabolism | Q44733671 | ||
| Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women | Q46584454 | ||
| A Specific Radioimmunoassay for the Growth Hormone (GH)-Dependent Somatomedin-Binding Protein: Its Use for Diagnosis of GH Deficiency | Q46807370 | ||
| Circulating binding proteins for the insulinlike growth factors | Q47874668 | ||
| Reduced bone mineral density in patients with adult onset growth hormone deficiency. | Q55065920 | ||
| Effect of Growth Hormone on Skeletal Mass in Adult Dogs | Q59068883 | ||
| P433 | issue | 6 | |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 715-724 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Effect of recombinant human growth hormone in elderly osteoporotic women | |
| P478 | volume | 51 |
| Q43725575 | Bone metabolism and body composition in Japanese patients with active acromegaly |
| Q36084036 | Clinical effects of growth hormone on bone: a review |
| Q34043294 | Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis |
| Q35011714 | Ghrelin in the regulation of body weight and metabolism |
| Q37147591 | Growth hormone, insulin-like growth factors, and the skeleton |
| Q34182027 | Growth hormone: current and future therapeutic applications |
| Q37257924 | Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults |
| Q38296081 | Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women |
| Q39527508 | Skeletal effects of growth hormone and insulin-like growth factor-I therapy. |
| Q34014324 | The aging process: where are the drug opportunities? |
| Q37573464 | Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia |
Search more.